BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33210835)

  • 1. Neuroretinal dysfunction revealed by a flicker electroretinogram correlated with peripheral nerve dysfunction and parameters of atherosclerosis in patients with diabetes.
    Kawai M; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Asano-Hayami E; Ejima Y; Kasagi R; Nagao E; Sugiura-Roth Y; Nakai-Shimoda H; Nakayama T; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakamura J; Kamiya H
    J Diabetes Investig; 2021 Jul; 12(7):1236-1243. PubMed ID: 33210835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve conduction velocity is negatively associated with intima-media thickness and brachial-ankle pulse wave velocity in men with type 2 diabetes mellitus.
    Tanaka S; Kanazawa I; Sugimoto T
    PLoS One; 2018; 13(12):e0209503. PubMed ID: 30571795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: A quantitative, but easy-to-use, prediction model.
    Kamiya H; Shibata Y; Himeno T; Tani H; Nakayama T; Murotani K; Hirai N; Kawai M; Asada-Yamada Y; Asano-Hayami E; Nakai-Shimoda H; Yamada Y; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Baba M; Nakamura J
    J Diabetes Investig; 2021 Apr; 12(4):583-591. PubMed ID: 32799422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified electrophysiological approach combining a point-of-care nerve conduction device and an electrocardiogram produces an accurate diagnosis of diabetic polyneuropathy.
    Hayashi Y; Himeno T; Shibata Y; Hirai N; Asada-Yamada Y; Sasajima S; Asano-Hayami E; Motegi M; Asano S; Kato M; Nakai-Shimoda H; Tani H; Miura-Yura E; Morishita Y; Kondo M; Tsunekawa S; Nakayama T; Nakamura J; Kamiya H
    J Diabetes Investig; 2024 Jun; 15(6):736-742. PubMed ID: 38421109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of retinal thickness measured by optical coherence tomography correlate with neurophysiological measures in diabetic polyneuropathy.
    Yamada Y; Himeno T; Tsuboi K; Shibata Y; Kawai M; Asada-Yamada Y; Hayashi Y; Asano-Hayami E; Hayami T; Ishida Y; Ejima Y; Motegi M; Asano S; Kato M; Nagao E; Nakai-Shimoda H; Ishikawa T; Morishita Y; Kondo M; Tsunekawa S; Kato Y; Nakayama T; Kamei M; Nakamura J; Kamiya H
    J Diabetes Investig; 2021 Aug; 12(8):1430-1441. PubMed ID: 33300294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with peripheral neuropathy in type 2 diabetes: Subclinical versus confirmed neuropathy.
    Unmar Y; Zafar MI; Gao F
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):337-342. PubMed ID: 28585130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.
    Sharma S; Vas PR; Rayman G
    J Diabetes Sci Technol; 2015 Jan; 9(1):123-31. PubMed ID: 25231114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications.
    Iwamoto Y; Nakanishi S; Itoh T; Nakao E; Sugisaki T; Kusano T; Ohnishi M; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Hemmi S; Kimura T; Tatsumi F; Shimoda M; Mune T; Kaku K; Kaneto H
    Front Endocrinol (Lausanne); 2022; 13():1054934. PubMed ID: 36387868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the severity of diabetic polyneuropathy aids in predicting the risk of developing diabetic complications in patients with untreated diabetes.
    Horinouchi S; Deguchi T; Mukai M; Ijuin A; Kawamoto Y; Nishio Y
    Front Endocrinol (Lausanne); 2024; 15():1380970. PubMed ID: 38559690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus.
    Picconi F; Mataluni G; Ziccardi L; Parravano M; Di Renzo A; Ylli D; Pasqualetti P; Studer V; Chioma L; Marfia GA; Frontoni S
    J Diabetes Res; 2018; 2018():9763507. PubMed ID: 30402503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
    Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
    Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of left ventricular myocardial dysfunction with diabetic polyneuropathy.
    Tabako S; Harada M; Sugiyama K; Ohara H; Ikeda T
    J Med Ultrason (2001); 2019 Jan; 46(1):69-79. PubMed ID: 30155803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device.
    Zeng Y; Cao D; Yang D; Zhuang X; Yu H; Hu Y; Zhang Y; Yang C; He M; Zhang L
    Doc Ophthalmol; 2020 Jun; 140(3):211-220. PubMed ID: 31720980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart rate-corrected QT interval: A novel diagnostic biomarker for diabetic peripheral neuropathy.
    Jiang AJ; Gu H; Feng ZR; Ding Y; Xu XH; Yin GP; Zhang WL; Shen ZY; Li Q
    J Diabetes Investig; 2022 May; 13(5):850-857. PubMed ID: 34932277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus.
    Pei Y; Shu Y; Deng B; Liu Y
    BMC Endocr Disord; 2023 May; 23(1):98. PubMed ID: 37143027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilirubin is inversely related to diabetic peripheral neuropathy assessed by sural nerve conduction study.
    Abe K; Maeda Y; Matsuzaki C; Yokomizo H; Inoue T; Sonoda N; Ogawa Y; Inoguchi T
    J Diabetes Investig; 2021 Nov; 12(11):2028-2035. PubMed ID: 33949141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and diabetic peripheral neuropathy: A multi-centre nerve conduction study among Chinese patients with type 2 diabetes.
    Pang C; Yu H; Cai Y; Song M; Feng F; Gao L; Li K; Chen Y; Xie J; Cheng Y; Lin E; Pan X; Zhang W; Deng B
    Diabetes Metab Res Rev; 2023 Oct; 39(7):e3679. PubMed ID: 37337761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes.
    Pritchard N; Edwards K; Russell AW; Perkins BA; Malik RA; Efron N
    Diabetes Care; 2015 Apr; 38(4):671-5. PubMed ID: 25573881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of a mydriasis-free, full-field flicker ERG device in the detection of diabetic retinopathy.
    Değirmenci MFK; Demirel S; Batıoğlu F; Özmert E
    Doc Ophthalmol; 2018 Dec; 137(3):131-141. PubMed ID: 30334119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?
    Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW
    J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.